Factors associated with the development of atrial fibrillation in patients with rheumatic mitral stenosis

International Journal of Cardiovascular Imaging

Volumn 26, Issue 5, 2010, Pages 547-552

  Ozaydin, Mehmet ^a   Turker, Yasin ^b   Varol, Ercan ^a   Alaca, Sule ^a   Erdogan, Dogan ^a   Yilmaz, Nigar ^b   Dogan, Abdullah ^a  

^a SULEYMAN DEMIREL UNIVERSITY   (Turkey)

^b Gulkent Hospital   (Turkey)

Author keywords

Atrial fibrillation; Inflammation; Mitral stenosis

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CARBOHYDRATE ANTIGEN; CARBOHYDRATE ANTIGEN 125; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE; UNCLASSIFIED DRUG; WARFARIN; BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FUNCTIONAL STATUS; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE STENOSIS; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RHEUMATIC MITRAL STENOSIS; RISK ASSESSMENT; RISK FACTOR; SINUS RHYTHM; ANALYSIS OF VARIANCE; BLOOD; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; ECHOGRAPHY; HEART ATRIUM; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REGRESSION ANALYSIS; RHEUMATIC HEART DISEASE;

ANALYSIS OF VARIANCE; ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE STENOSIS; NATRIURETIC PEPTIDE, BRAIN; REGRESSION ANALYSIS; RHEUMATIC HEART DISEASE; RISK FACTORS;

EID: 77955506710     PISSN: 15695794     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10554-010-9609-0     Document Type: Article

References (42)

1. Selcuk MT, Selcuk H, Maden O et al (2007) Relationship between inflammation and atrial fibrillation in patients with isolated rheumatic mitral stenosis. J Heart Valve Dis 16:468-674
2. Kumagai K, Nakashima H, Saku K (2004) The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cardiovasc Res 62:105-111 (Pubitemid 38326816)
3. Chung MK, Martin DO, Sprecher D et al (2001) C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104:2886-2891 (Pubitemid 33139098)
4. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A (1997) Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96:1180-1184 (Pubitemid 27344221)
5. Watanabe M, Murakami M, Furukawa H, Nakahara H, Tanaka H, Sunamori M (2003) Decreased plasma brain natriuretic peptide levels after a successful maze procedure. J Heart Valve Dis 12:287-291 (Pubitemid 36675641)
6. Sanna T, Sonaglioni A, Pieroni M et al (2009) Baseline NT-Pro-BNP levels and arrhythmia recurrence in outpatients undergoing elective cardioversion of persistent atrial fibrillation: a survival analysis. Indian Pacing Electrophysiol J 9:15-24
7. Horie H, Tsutamoto T, Minai K, Hayashi M, Kito O, Kinoshita M (2000) Brain natriuretic peptide predicts chronic atrial fibrillation after ventricular pacing in patients with sick sinus syndrome. Jpn Cir J 64:965-970
8. Wazni OM, Martin DO, Marrouche NF, Natale A (2004) Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation 110:124-127 (Pubitemid 38924579)
9. Beck-da Silva L, de Bold A, Fraser M, Williams K, Haddad H (2004) BNP predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm. Can J Cardiol 20:1245-1248 (Pubitemid 39545560)
10. Lellouche N, Berthier R, Mekontso-Dessap A et al (2005) Usefulness of plasma B-type natriuretic peptide in predicting recurrence of atrial fibrillation one year after external cardioversion. Am J Cardiol 95:1380-1382 (Pubitemid 40719876)
11. Ucer E, Gungor B, Erdinler IC et al (2008) High sensitivity CRP levels predict atrial tachyarrhythmias in rheumatic mitral stenosis. ANE 13:31-38 (Pubitemid 351146580)
12. Kabukcu M, Arslantas E, Ates I, Demircioglu F, Ersel F (2005) Clinical, echocardiographic, and hemodynamic characteristics of rheumatic mitral valve stenosis and atrial fibrillation. Angiology 56:159-163 (Pubitemid 40404470)
13. Arat-Ozkan A, Kaya A, Yigit Z et al (2005) Serum N-Terminal pro-BNP levels correlate with symptoms and echocardiographic findings in patients with mitral stenosis. Echocardiography 22:473-478 (Pubitemid 40934428)
14. Eryol NK, Dogan A, Ozdogru I, Inanc MT, Kaya MG, Kalay N (2007) The relationship between the level of plasma B-type natriuretic peptide and mitral stenosis. Int J Cardiovasc Imaging 23:569-574
15. Letsas KP, Filippatos GS, Pappas LK et al (2009) Determinants of plasma NT-pro-BNP levels in patients with atrial fibrillation and preserved left ventricular ejection fraction. Clin Res Cardiol 98:101-106
16. Duman C, Ercan E, Tengiz I, Bozdemir H, Ercan HE, Nalbantgil I (2003) Elevated serum CA 125 levels in mitral stenotic patients with heart failure. Cardiology 100:7-10 (Pubitemid 37140412)
17. Sahn DJ, DeMaria A, Kisslo J, Weyman A (1978) Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072-1083 (Pubitemid 9091990)
18. Edep ME, Shirani J, Wolf P, Brown DL (2000) Matrix matalloproteinase expression in nonrheumatic aortic stenosis. Cardiovasc Pathol 9:281-286
19. Chiu-Braga YY, Hayashi SY, Schafranski M, Messias-Reason IJ (2006) Further evidence of inflammation in chronic rheumatic valve disease (CRVD): high levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein. Int J Cardiol 109:275-276
20. Gölbasi Z, Uçar O, Keles T et al (2002) Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease evidence of ongoing inflammation. Eur J Heart Fail 4:593-595 (Pubitemid 35278511)
21. Krasuski RA, Bush A, Kay JE et al (2003) C-reactive protein elevation independently influences the procedural success of percutaneous balloon mitral valve commissurotomy. Am Heart J 146:1099-1104 (Pubitemid 37500788)
22. Yetkin E, Erbay AR, Ileri M et al (2001) Levels of circulating adhesion molecules in rheumatic mitral stenosis. Am J Cardiol 88:1209-1211 (Pubitemid 33043864)
23. Alyan O, Metin F, Kacmaz F et al (2009) High levels of high sensitivity C-reactive protein predict the progression of chronic rheumatic mitral stenosis. J Thromb Thrombolysis 28:63-69
24. Wiese S, Breyer T, Dragu A et al (2000) Gene expression of brain natriuretic peptide in isolated atrial and ventricular myocardium: influence of angiotensin II and diastolic fiber length. Circulation 102:3074-3079
25. Shin DI, Jaekel K, Schley P et al (2005) Plasma levels of NT-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion. Z Kardiol 94:795-800 (Pubitemid 43029746)
26. Beck-da-Silva L, de Bold A, Fraser M, Williams K, Haddad H (2004) Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm. Can J Cardiol 20:1245-1248 (Pubitemid 39545560)
27. Kurosaki K, Tada H, Hashimoto T et al (2007) Plasma natriuretic peptide concentrations as a predictor for successful catheter ablation in patients with drug-refractory atrial fibrillation. Circ J 71:313-320 (Pubitemid 46409531)
28. Wozakowska-Kaplon B, Opolski G (2003) Concomitant recovery of atrial mechanical and endocrine function after cardioversion in patients with persistent atrial fibrillation. J Am Coll Cardiol 41:1716-1720 (Pubitemid 36584241)
29. Ohta Y, Shimada T, Yoshitomi H et al (2001) Drop in plasma brain natriuretic peptide levels after successful direct current cardioversion in chronic atrial fibrillation. Can J Cardiol 17:415-420 (Pubitemid 32492432)
30. Wozakowska-Kaplon B, Opolski G (2004) Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study. Int J Cardiol 96:171-176 (Pubitemid 38979895)
31. Lee SH, Jung JH, Choi SH et al (2006) Determinants of brain natriuretic peptide levels in patients with lone atrial fibrillation. Circ J 70:100-104
32. Inoue S, Murakami Y, Sano K, Katoh H, Shimada T (2000) Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail 6:92-96 (Pubitemid 30439442)
33. Mollmann H, Weber M, Elsasser A et al (2008) NT-ProBNP predicts rhythm stability after cardioversion of lone atrial fibrillation. Circ J 72:92-925
34. Buob A, Jung J, Siaplaouras S, Neuberger HR, Mewis C (2006) Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation. PACE 29:559-563 (Pubitemid 43886605)
35. Goetze JP, Friis-Hansen L, Rehfeld JF, Nilsson B, Svendsen JH (2006) Atrial secretion of B-type natriuretic peptide. Eur Heart J 27:1648-1650 (Pubitemid 44025348)
36. Kenemans P, Yedema CA, Bon GG (1993) CA 125 in gynecological pathology: a review. Eur J Obstet Gynecol Reprod Biol 49:115-124
37. Nagele H, Bahlu M, Klapdor R, Schaeperkoeter D, Rfdiger W (1999) CA 125 and its relation to cardiac function. Am Heart J 137:1044-1049 (Pubitemid 30040726)
38. Varol E, Ozaydin M, Dogan A, Kosar F (2005) Tumour marker levels in patients with chronic heart failure. European J Heart Fail 7:840-843 (Pubitemid 41125903)
39. D'Aloia A, Faggiano P, Aurigemma G et al (2003) Serum levels of carbohydrate antigen 125 in patients with chronic heart failure. Relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities and shortterm prognosis.. J Am Coll Cardiol 41:1805-1811 (Pubitemid 36584256)
40. Ozaydin M, Turker Y, Erdogan D et al (2008) The association between previous statin use and development of atrial fibrillation in patients presenting with acute coronary syndrome. Int J Cardiol, 22 Dec. 2008. [Epub ahead of print]
41. Losi MA, Betocchi S, Aversa M et al (2004) Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy. Am J Cardiol 94:895-900 (Pubitemid 39359175)
42. Grigioni F, Avierinos JF, Ling LH et al (2002) Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. J Am Coll Cardiol 40:84-92 (Pubitemid 34701381)